A tort reform group wants the US FDA to regulate advertisements soliciting plaintiffs for Rx drug and medical device product liability suits, just as it does for manufacturer advertising.
A report commissioned by the U.S. Chamber Institute for Legal Reform recommends that Congress give the agency the authority to monitor lawsuit ads for misleading, scientifically unsupported, or false information...